0KFHRevenio Group Oyj
LSE · GB · Healthcare · reveniogroup.fi
14.32EUR-0.56%Mkt Cap: P/E: 20.84

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company of…

Key Statistics

Company
Market Cap
Enterprise Value413.81M $
Revenue (TTM)120.70M $
Gross Profit84.42M $
Net Income (TTM)17.08M $
Revenue/Share4.520 USD
Last Price14.32 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees246
CountryGB
SectorHealthcare
Industry
ISINFI0009010912
Valuation
P/E (Trailing)20.84
P/E (Forward)
PEG
EV/EBITDA15.86
EV/Revenue3.43
P/S
P/B3.34
EPS (TTM)0.69
EPS (Forward)
52W Range
14.320% of range14.40
52W High14.40 EUR
52W Low14.32 EUR
Profitability
Gross Margin69.94%
Oper. Margin8.43%
EBITDA Margin21.61%
Profit Margin14.15%
ROE13.70%
ROA9.17%
Growth
Revenue Growth4.60%
Earnings Growth-41.40%
Cash Flow & Leverage
Operating CF24.06M $
CapEx (TTM)
FCF Margin12.47%
FCF Yield
Net Debt-11.52M $
Net Debt/EBITDA-0.44
Balance Sheet
Debt/Equity9.21
Current Ratio2.27
Quick Ratio1.76
Book Value/Sh4.317 EUR
Cash/Share0.7880 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.4400 EUR
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Splits
Last Split2:1
Split DateMar 20, 2020
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.23.53M
Float25.16M
Insiders9.65%
Institutions50.98%
Technical
SMA 5026.01 (-44.9%)
SMA 20025.59 (-44.0%)
Beta0.85
S&P 52W Chg20.80%
Avg Vol (30d)9.00K
Avg Vol (10d)1.20K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)